Semi-Annual Consolidated Statement Of Cash Flows

ZERIA PHARMCEUTICAL CO., LTD. - Filing #7541241

Concept As at
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-03-31
As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
6,412,933,000 JPY
4,970,794,000 JPY
Depreciation
3,031,173,000 JPY
2,466,358,000 JPY
Amortization of goodwill
363,836,000 JPY
354,879,000 JPY
Interest and dividend income
-238,849,000 JPY
-184,597,000 JPY
Interest expenses
226,110,000 JPY
181,259,000 JPY
Increase (decrease) in retirement benefit liability
-17,638,000 JPY
109,324,000 JPY
Increase (decrease) in provision for bonuses
-562,105,000 JPY
-514,895,000 JPY
Decrease (increase) in trade receivables
-2,804,465,000 JPY
-1,289,682,000 JPY
Decrease (increase) in inventories
-824,917,000 JPY
-409,623,000 JPY
Increase (decrease) in trade payables
1,034,301,000 JPY
193,809,000 JPY
Other, net
-286,874,000 JPY
-117,947,000 JPY
Subtotal
5,391,092,000 JPY
5,684,428,000 JPY
Interest and dividends received
238,593,000 JPY
184,616,000 JPY
Interest paid
-216,497,000 JPY
-180,360,000 JPY
Income taxes paid
-448,416,000 JPY
-356,493,000 JPY
Net cash provided by (used in) operating activities
4,964,771,000 JPY
5,332,190,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,395,136,000 JPY
-908,651,000 JPY
Purchase of investment securities
-2,313,000 JPY
-132,488,000 JPY
Proceeds from sale of investment securities
1,000 JPY
215,908,000 JPY
Other, net
99,315,000 JPY
17,787,000 JPY
Net cash provided by (used in) investing activities
-2,186,567,000 JPY
-963,476,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
500,000,000 JPY
500,000,000 JPY
Repayments of long-term borrowings
-2,824,420,000 JPY
-3,028,710,000 JPY
Purchase of treasury shares
-323,000 JPY
-538,398,000 JPY
Dividends paid
-966,355,000 JPY
-798,347,000 JPY
Net cash provided by (used in) financing activities
-2,285,403,000 JPY
-2,119,276,000 JPY
Dividends paid to non-controlling interests
-2,308,000 JPY
-3,929,000 JPY
Effect of exchange rate change on cash and cash equivalents
1,756,142,000 JPY
1,340,254,000 JPY
Net increase (decrease) in cash and cash equivalents
2,248,943,000 JPY
3,589,691,000 JPY
Cash and cash equivalents
18,343,022,000 JPY
16,094,078,000 JPY
15,168,974,000 JPY
11,579,282,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.